Accropeutics has developed a robust pipeline focusing on inflammation, fibrosis, autoimmune diseases and cancer
| Asset | Rights | Indication | Discovery | Pre-Clinical | IND | Phase l | Phase lb/ll |
|---|---|---|---|---|---|---|---|
|
AC-101 Learn more |
Global | IBD |
|
||||
| Global | Blau Syndrome |
|
|||||
|
AC-201 Learn more |
Global(Excluding Greater China,Fosun Pharma) | PsO |
|
||||
| Global(Excluding Greater China,Fosun Pharma) | NIU |
|
|||||
|
AC-003 Learn more |
Global | aGVHD |
|
||||
| Global | IPF |
|
|||||
|
Confidential Targets |
Global | RA, AD, HS |
|
||||
|
Confidential Targets |
Global | Asthma, COPD |
|
